Novel dexamethasone formulation shows efficacy and safety with once-daily use
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
A forum for researchers, students and applicants in the field of cyclodextrin technology
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents provides sound data on the utility of
ICND 2020 is going to be held during April 15-17, 2020 in Radisson Narita, Tokyo, Japa in collaboration with European
A recent review of prof. Mazzaglia’s group gives an overview on CD-based nanomaterials of biological relevance focusing on CD self-assembly
“3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry” will be held in Barcelona, Spain on March 23-24, 2020. This is
International Conference on Nanomedicine and Nanotechnology is going to be held in Dublin, Ireland on May 20-21, 2020, focusing on the theme “Empowering success
Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics (edited by Prashant Kesharwani, Kishore Paknikar and Virendra Gajbhiye) and published by
In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from
A paper has just come out in Macromolecular Rapid Communications highlighting the potential benefits of cyclodextrin-based macromolecular systems as cholesterol-mopping